Lilly Falls on Oral Obesity Pill as FDA Decision Looms
Eli Lilly stock fell about 5% as investors awaited the FDA's April decision on orforglipron. Novo Nordisk's intensifi...
Compare volatility levels for Dividend Aristocrats ETF and apply practical tactics to manage risk and maximize stability.
22,003 articlesEli Lilly stock fell about 5% as investors awaited the FDA's April decision on orforglipron. Novo Nordisk's intensifi...
Louisiana’s sales tax landscape is a maze of local rules and rates. Centralizing louisiana’s sales collection promise...
AI-driven settlements now move money and data across borders at scale. The lingering challenge mirrors a 19th-century...
When Medicare Part B premiums topped the $200 mark, many retirees felt the impact in real time. This guide explains w...
Analysts see a wall street pros upside for Royal Caribbean as 2026 capacity and earnings guidance point to a stronger...
A bipartisan proposal aims to cap Social Security benefits for the wealthiest couples to address long-term solvency c...
Exelon is tapping into accelerating AI data-center demand in Illinois, with Citi signaling upside and a $58 target by...
A longtime investor reevaluates the urge to claim Social Security at 62, choosing to wait for bigger monthly checks a...
TON climbs from about $1.30 to $2.50 in three days as Telegram signals a major governance shift, slashing fees and ta...
In Q1 2026, new homes held prices steady while resale values declined, signaling a pricing strategy where discounts r...
Investors eye Omada Health as it reports Q1 2026 results. This analysis breaks down the earnings narrative, key metri...
When you sign up for Medicare, costs aren’t just the monthly premiums. The one early move can dramatically reduce lon...